MedTrace Logo

Fever In Palliative Care

NCT07106073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2025-08-06

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the frequency and characteristics of fever in terminally ill adult patients admitted to the Infectious Diseases Hospice at Luigi Sacco Hospital in Milan. The main questions it aims to answer are:

* How often does fever occur in terminally ill patients during hospice care?
* What are the typical features of fever in this population in terms of intensity, duration, possible causes, and treatment strategies?
* Is there any correlation between the occurrence of fever and patients' clinical characteristics, such as age, sex, BMI, comorbidities, and palliative prognostic scores (PPS and PPI)?

Participants will be adult patients (≥18 years) with a life expectancy of more than 24 hours and less than 3 months.

During their stay, the following data will be collected:

* Presence and characteristics of fever (temperature, duration, treatment, suspected cause)
* Clinical and demographic information (e.g., age, sex, BMI, comorbidities, performance status)
* Details on hospitalization (e.g., symptom burden, need for palliative sedation, outcome)

The study will enroll approximately 250 patients consecutively over a 48-week period. No additional procedures or treatments beyond standard clinical care will be required.

Conditions

  • Fever
  • Palliative Care
  • Terminal Illness

Interventions

OTHER

Collection of demographic, anthropometric and clinical data.

Data collected is: * demographic data: age, sex; * anthropometric data: weight, height, body mass index; * clinical data: * Palliative Performance Scale; * Palliative Prognostic Index; * comorbidities; * therapy; * presence of medical devices; * presence of pressure injuries; * time on waiting list; * place of care; * primary diagnosis; * length of stay; * symptom burden at admission (Edmonton Symptom Assessment System); * onset of fever and its characteristics (duration, intensity, treatment, etiology); * need for sedation (duration, refractory symptom(s)); * outcome.

Sponsors & Collaborators

  • Stefania Cheli

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-27
Primary Completion
2025-06-27
Completion
2025-07-22

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07106073 on ClinicalTrials.gov